NASDAQ$HURN

Huron Consulting Group Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Huron Consulting Group Inc. announced record fourth quarter 2024 financial results, with significant increases in revenues, net income, and adjusted EBITDA.

Huron Consulting Group Inc. reported record revenues before reimbursable expenses of $388.4 million in Q4 2024, a 14.5% increase from the prior year. Net income surged to $34.0 million, up from $2.8 million in Q4 2023, and diluted EPS reached $1.84. Adjusted EBITDA also saw a substantial increase to $56.8 million.

  • Revenues before reimbursable expenses increased by 14.5% to a record $388.4 million in Q4 2024.
  • Net income significantly increased to $34.0 million in Q4 2024, compared to $2.8 million in Q4 2023.
  • Diluted earnings per share rose to $1.84 in Q4 2024, up from $0.15 in Q4 2023.
  • Adjusted EBITDA increased by 37.3% to $56.8 million in Q4 2024.

Headline financials

Total Revenue

$388M

Previous: $350M+11.0%
EPS (adj)

$1.90

Previous: $1.29+47.3%
Revenue Professionals

4.7K

Previous: 4.5K+5.0%
Managed Services Prof.

1.5K

Previous: 1.1K+45.7%
Total Professionals

6.2K

No prior period
Consulting Utilization

77.2%

Previous: 76.8%+0.5%
Digital Utilization

77.7%

Previous: 80.5%-3.5%
Capital Expenditures

-$7.21M

Previous: -$10.4M+30.8%
Net Income

$34M

Previous: $2.8M+1113.9%
Operating Income

$47.1M

Previous: $29.9M+57.6%
Gross Profit

$122M

Previous: $105M+16.0%

Revenue & EPS history

Huron · Revenue · Quarterly

$388M

Q4 2024+11%vs Q4 2023
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Revenue by segment

Huron · $358M total across 3 segments · Q3 2023

  • Healthcare
    $179M+36.4%
  • Education
    $111M+17.7%
  • Commercial
    $68M+13.8%

Forward guidance

Huron provides full year 2025 guidance, anticipating revenues before reimbursable expenses in the range of $1.58 billion to $1.66 billion, adjusted EBITDA as a percentage of revenues before reimbursable expenses in the range of 14.0% to 14.5%, and adjusted diluted earnings per share in the range of $6.80 to $7.60.

Tailwinds

  • Anticipated revenue growth for full year 2025.
  • Expected strong adjusted EBITDA as a percentage of revenues.
  • Projected increase in adjusted diluted earnings per share.
  • Continued focus on accelerating growth in healthcare and education industries.
  • Expanding presence in commercial industries.

Headwinds

  • Guidance is based on currently available information and subject to market conditions.
  • Potential for fluctuations in utilization rates and billing rates.
  • Dependence on new business and retention of current clients.
  • Risks related to maintaining third-party provider relationships and strategic alliances.
  • Uncertainties regarding the successful integration of acquired businesses.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.8%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+0.2%

Avg return

30 days after

60%

41 / 68 earnings

Positive

+19.6%

Q3 2018

Best reaction

-24.2%

Q3 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%-9.2%-19.0%
Q4 2025+5.8%+14.3%-2.9%
Q3 2025+11.2%+8.7%+8.0%
Q1 2025-0.8%+9.1%+5.1%
Q4 2024+18.2%+18.4%+13.5%
Q3 2024+11.5%+10.5%+18.8%
Q2 2024-3.1%-4.4%-4.9%
Q1 2024-7.1%-7.9%-8.3%
Q4 2023-12.3%-7.1%-9.7%
Q3 2023+1.0%+2.6%+8.1%
Q2 2023+15.6%+20.9%+21.8%
Q1 2023-12.6%-14.5%-5.8%
Q4 2022+15.9%+14.0%+13.5%
Q3 2022+3.0%+2.2%+7.2%
Q2 2022+1.9%+2.2%+4.6%
Q1 2022+6.1%+2.4%+16.3%
Q4 2021+3.3%+4.6%-1.9%
Q3 2021-0.0%+3.3%-7.2%
Q2 2021+3.5%-0.4%+4.9%
Q1 2021+0.1%-0.7%-6.8%
Q4 2020-9.2%-13.9%-16.0%
Q3 2020+7.3%+1.7%+15.8%
Q2 2020+8.9%+6.8%+0.8%
Q1 2020-16.8%-22.3%-18.1%
Q4 2019+1.7%-8.5%-27.2%
Q3 2019+9.6%+10.3%+11.0%
Q2 2019+10.5%+5.9%+10.9%
Q1 2019+0.6%+2.0%+2.1%
Q4 2018-12.1%-12.5%-12.0%
Q3 2018+19.6%+16.0%+20.4%
Q2 2018+4.1%+6.2%+13.3%
Q1 2018-6.4%-7.7%+8.1%
Q4 2017-17.5%-15.9%-10.1%
Q3 2017+4.6%+4.6%+9.6%
Q2 2017-13.8%-15.4%-27.4%
Q1 2017+2.8%+0.0%-6.6%
Q4 2016+1.5%-7.5%-10.7%
Q3 2016-15.3%-12.3%-8.2%
Q2 2016-3.1%-4.5%-1.2%
Q1 2016-6.0%
Q4 2015-3.1%
Q3 2015-24.2%
Q2 2015+10.7%
Q4 2011+10.7%
Q1 2015-8.1%
Q4 2014-13.1%
Q3 2014+3.1%
Q2 2014+1.8%
Q1 2014+13.7%
Q4 2013+2.3%
Q3 2013-6.2%
Q2 2013+8.1%
Q1 2013+0.9%
Q4 2012+3.4%
Q3 2012-9.1%
Q2 2012-0.6%
Q1 2012+2.5%
Q3 2011+7.1%
Q2 2011+6.7%
Q1 2010+1.5%
Q1 2011+1.2%
Q4 2010-2.6%
Q4 2008-2.6%
Q3 2009+13.7%
Q3 2010+13.7%
Q2 2009-3.9%
Q4 2009-3.9%
Q2 2010-3.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro